ロード中...

Low-Dose Electron Beam Radiation and Romidepsin Therapy for Symptomatic Cutaneous T-Cell Lymphoma Lesions

BACKGROUND: Romidepsin is a structurally unique histone deacetylase inhibitor FDA-approved for therapy of relapsed or refractory cutaneous T-cell lymphoma (CTCL). Localized electron beam radiation therapy (LEBT) is standard practice in the care of patients with chronically traumatized and painful le...

詳細記述

保存先:
書誌詳細
主要な著者: Akilov, O.E., Grant, C., Frye, R., Bates, S., Piekarz, R., Geskin, L.J.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3386371/
https://ncbi.nlm.nih.gov/pubmed/22372971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2133.2012.10905.x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!